Activity and Health in Nursing Homes

Frailty Clinical Trial

Official title:

The Association Between Physical Behavior, Sleep and Neuropsychiatric Symptoms in Nursing Homes

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05037084
• Other study ID #: 157470
• Status: Active, not recruiting
• Start date: August 30, 2021
• Est. completion date: May 31, 2022

Study information

• Verified date: March 2022
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

There is expected to be an increased need for full time nursing homes as the increase in number of older adults increases and the rate of dementia diagnosis happens simultaneous with the decrees of healthcare personnel the years to come. A lift in knowledge is needed to provide a better and more efficient healthcare to be better equipped to meet this societal challenge. Physical activity and sleep are important indicators of health, but also on effect of treatment and care for this frail population. Comprehensive mapping of personnel time spent on different tasks and older adults' physical function throughout a week gives a unique opportunity to gain new knowledge about everyday life in nursing homes. The main aim of this project is to describe associations between physical behavior, sleep and symptoms in residents in nursing homes in Trondheim Municipality and combine these with personnel time spent on different working tasks.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 1200
• Est. completion date: May 31, 2022
• Est. primary completion date: May 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

All residents in nursing homes in Trondheim Municipality.

Exclusion Criteria:

Terminal residents or residents that can not stand or walk a few steps independently.

Related Conditions & MeSH terms

• Frailty
• Old Age

Intervention

Other:
• no intervention
no intervention

Locations

Country	Name	City	State
Norway	Trondheim Kommune	Trondheim

Sponsors (2)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology	Trondheim Kommune

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Axivity accelerometer	Activity monitoring	7 days
Primary	Somnofy sleepmonitor	Sleep monitoring	7 days
Primary	Short Physical Performance Battery (SPPB)	Measurement of physical function	Baseline
Secondary	Time register	Time used on different tasks during the work day	7 days
Secondary	Neuropsychiatric Inventory (NPI)	provide a brief assessment of neuropsychiatric symptomatology in routine clinical practice settings	Baseline
Secondary	Dementia Staging Instrument (CDR)	characterize six domains of cognitive and functional performance applicable to Alzheimer disease and related dementias	Baseline